Zydus Cadila Gets Usfda Nod For Overactive Bladder Treatment Drug

Zydus Cadila Gets Usfda Nod For Overactive Bladder Treatment Drug

By, Admin 21 October 2020

Drug Firm Zydus Cadila On Tuesday Said It Has Received Final Approval From The Us Health Regulator To Market Solifenacin Succinate Tablets, Used For Treatment Of Overactive Bladder.The Company Has Received Final Approval From The United States Food And Drug Administration (Usfda) To Market Solifenacin Succinate Tablets, In The Strengths Of 5 Mg And 10 Mg, Zydus Cadila, Part Of The Cadila Healthcare Group, Said In A Regulatory Filing.Solifenacin Succinate Is A Symptomatic Treatment Of Urge Incontinence And/Or Increased Urinary Frequency And Urgency As May Occur In Patients With Overactive Bladder Syndrome.The Company Said The Newly-Approved Medication Will Be Manufactured At The Group'S Formulation Manufacturing Facility At The Special Economic Zone, Ahmedabad.The Group Now Has 309 Approvals And Has So Far Filed Over 390 Abbreviated New Drug Applications Since The Commencement Of The Filing Process In Financial Year 2003-04.Shares Of Cadila Healthcare Were Trading 0.01 Per Cent Higher At Rs 422.55 On Bse.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!